Correlation Between Navidea Biopharmaceutica and CERo Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Navidea Biopharmaceutica and CERo Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Navidea Biopharmaceutica and CERo Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Navidea Biopharmaceuticals and CERo Therapeutics Holdings, you can compare the effects of market volatilities on Navidea Biopharmaceutica and CERo Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Navidea Biopharmaceutica with a short position of CERo Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Navidea Biopharmaceutica and CERo Therapeutics.

Diversification Opportunities for Navidea Biopharmaceutica and CERo Therapeutics

0.75
  Correlation Coefficient

Poor diversification

The 3 months correlation between Navidea and CERo is 0.75. Overlapping area represents the amount of risk that can be diversified away by holding Navidea Biopharmaceuticals and CERo Therapeutics Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on CERo Therapeutics and Navidea Biopharmaceutica is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Navidea Biopharmaceuticals are associated (or correlated) with CERo Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of CERo Therapeutics has no effect on the direction of Navidea Biopharmaceutica i.e., Navidea Biopharmaceutica and CERo Therapeutics go up and down completely randomly.

Pair Corralation between Navidea Biopharmaceutica and CERo Therapeutics

If you would invest  0.60  in CERo Therapeutics Holdings on August 28, 2024 and sell it today you would earn a total of  1.38  from holding CERo Therapeutics Holdings or generate 230.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy5.26%
ValuesDaily Returns

Navidea Biopharmaceuticals  vs.  CERo Therapeutics Holdings

 Performance 
       Timeline  
Navidea Biopharmaceutica 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Navidea Biopharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, Navidea Biopharmaceutica is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.
CERo Therapeutics 

Risk-Adjusted Performance

13 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in CERo Therapeutics Holdings are ranked lower than 13 (%) of all global equities and portfolios over the last 90 days. In spite of fairly inconsistent basic indicators, CERo Therapeutics showed solid returns over the last few months and may actually be approaching a breakup point.

Navidea Biopharmaceutica and CERo Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Navidea Biopharmaceutica and CERo Therapeutics

The main advantage of trading using opposite Navidea Biopharmaceutica and CERo Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Navidea Biopharmaceutica position performs unexpectedly, CERo Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in CERo Therapeutics will offset losses from the drop in CERo Therapeutics' long position.
The idea behind Navidea Biopharmaceuticals and CERo Therapeutics Holdings pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.

Other Complementary Tools

Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios